Bright Cell, Inc.
Clinical trials sponsored by Bright Cell, Inc., explained in plain language.
-
Experimental infusion aims to restore ovarian function in young women with early menopause
Disease control Not yet recruitingThis early-stage study tests the safety of a new drug called YB-1113 for women under 40 with premature ovarian insufficiency (POI), a condition that causes early menopause and infertility. Six participants will receive the drug through an IV infusion. Researchers will monitor sid…
Phase: PHASE1 • Sponsor: Bright Cell, Inc. • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New wrinkle shot aims to smooth deep smile lines
Symptom relief Not yet recruitingThis early-stage study tests a new treatment called BC-101 for moderate to severe smile lines (nasolabial folds). Nine healthy adults who are unhappy with their deep wrinkles will receive injections under the skin. The main goal is to check safety and see if the treatment reduces…
Phase: PHASE1 • Sponsor: Bright Cell, Inc. • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC